Home/Filings/4/0001628280-24-026207
4//SEC Filing

MORE ROBERT J 4

Accession 0001628280-24-026207

CIK 0001706431other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 12:08 PM ET

Size

7.7 KB

Accession

0001628280-24-026207

Insider Transaction Report

Form 4
Period: 2024-05-30
Transactions
  • Award

    Common Stock

    2024-05-30+8,00046,683 total
  • Award

    Stock Option (Right to Buy)

    2024-05-30+16,00016,000 total
    Exercise: $10.39From: 2025-05-30Exp: 2034-05-29Common Stock (16,000 underlying)
Holdings
  • Common Stock

    (indirect: See footnote)
    495,890
Footnotes (1)
  • [F1]The shares are held by APNG 1. The Reporting Person is a managing director of Alta Partners NextGen Fund I Management, LLC, which is the general partner of APNG I. The Reporting Person may be deemed to beneficially own the shares held by APNG 1, and disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Issuer

Vir Biotechnology, Inc.

CIK 0001706431

Entity typeother

Related Parties

1
  • filerCIK 0001207792

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 12:08 PM ET
Size
7.7 KB